Amedeo Smart

Free Medical Literature Service




  Free Subscription


1 AJR Am J Roentgenol
1 Am J Obstet Gynecol
3 Am J Respir Crit Care Med
3 Ann Intern Med
3 Antiviral Res
1 Br J Anaesth
28 Clin Infect Dis
7 Emerg Infect Dis
1 Infect Control Hosp Epidemiol
6 Int J Infect Dis
3 Intensive Care Med
8 J Infect
12 J Med Virol
1 J Travel Med
2 J Virol
2 Lancet
1 Lancet Infect Dis
6 MMWR Morb Mortal Wkly Rep
10 N Engl J Med
8 Nature
2 Radiology
3 Science
1 Travel Med Infect Dis

    AJR Am J Roentgenol

  1. BARRETO IL, Grajo JR, Brock DE, Magnelli L, et al
    A Health System's Response to the Ongoing Global Shortage of Iodinated Contrast Media.
    AJR Am J Roentgenol. 2022 Jun 22. doi: 10.2214/AJR.22.28060.
    >> Share

    Am J Obstet Gynecol

  2. TRIEBWASSER JE, Dhudasia MB, Mukhopadhyay S, Flannery DD, et al
    Assessment of SARS-CoV-2 serostatus and hypertensive disorders of pregnancy.
    Am J Obstet Gynecol. 2022 Jun 16. pii: S0002-9378(22)00458.
    >> Share

    Am J Respir Crit Care Med

  3. CHEN HY, Chang R, Wei JC
    Comments on Air Pollutant Exposures and COVID-19 Severity and Mortality.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1032.
    >> Share

    Susceptibility of Patients with Asthma to Poor Outcome of COVID-19.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202205-0978.
    >> Share

  5. CHEN Z, Sidell MA, Gilliland FD, Xiang AH, et al
    Reply to: Comments on Air Pollutant Exposures and COVID-19 Severity and Mortality.
    Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1148.
    >> Share

    Ann Intern Med

  6. SMITH CA, Barnes GD
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Venous Thromboembolism Prophylaxis in COVID-19: Making Sense of the Evidence.
    Ann Intern Med. 2022;175:HO2-HO3.
    >> Share

    Web Exclusive. Annals Story Slam - A Two-Year Long Blackjack Game: Decisions During COVID.
    Ann Intern Med. 2022;175:SS1.
    >> Share

    Web Exclusive. Annals Story Slam - The Prayer in the COVID Unit.
    Ann Intern Med. 2022;175:SS1.
    >> Share

    Antiviral Res

  9. KARIM M, Saul S, Ghita L, Sahoo MK, et al
    Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
    Antiviral Res. 2022 Jun 20:105367. doi: 10.1016/j.antiviral.2022.105367.
    >> Share

  10. ZHOU M, Liu Y, Cao J, Dong S, et al
    Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.
    Antiviral Res. 2022 Jun 19:105365. doi: 10.1016/j.antiviral.2022.105365.
    >> Share

  11. HERNANDEZ S, Feracci M, De Jesus CT, El Kazzi P, et al
    Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay.
    Antiviral Res. 2022 Jun 15:105364. doi: 10.1016/j.antiviral.2022.105364.
    >> Share


  12. WISE J
    Covid-19: UK makes first payments to compensate injury or death from vaccines.
    BMJ. 2022;377:o1565.
    >> Share

  13. KARAN A
    The covid-19 pandemic will end with public health tools, not clinical ones.
    BMJ. 2022;377:o1561.
    >> Share

  14. TANNE JH
    Covid-19 failures show the US needs a national public health system, commission finds.
    BMJ. 2022;377:o1552.
    >> Share

  15. SCOBIE S
    Covid-19: How has the pandemic differed across the four UK nations?
    BMJ. 2022;377:o1482.
    >> Share

  16. LI X, Ostropolets A, Makadia R, Shoaibi A, et al
    Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.
    BMJ. 2021;373:n1435.
    >> Share

  17. WISE J
    Covid-19: Omicron sub variants driving new wave of infections in UK.
    BMJ. 2022;377:o1506.
    >> Share

  18. TANNE JH
    Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s.
    BMJ. 2022;377:o1507.
    >> Share

  19. WISE J
    Covid-19: Long covid risk is lower with omicron than delta, researchers find.
    BMJ. 2022;377:o1500.
    >> Share

  20. PAGEL C
    The covid waves continue to come.
    BMJ. 2022;377:o1504.
    >> Share

    Br J Anaesth

  21. TSOLAKI V, Zakynthinos GE
    Simulation to minimise patient self-inflicted lung injury: are we almost there?
    Br J Anaesth. 2022 Jun 18. pii: S0007-0912(22)00245.
    >> Share

    Clin Infect Dis

  22. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    >> Share

  23. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  24. BORAH BF, Pringle J, Flaherty M, Oeltmann JE, et al
    High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont.
    Clin Infect Dis. 2022 Jun 24. pii: 6617336. doi: 10.1093.
    >> Share

  25. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    >> Share

  26. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  27. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  28. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  29. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  30. BOUTON TC, Atarere J, Turcinovic J, Seitz S, et al
    Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jun 23. pii: 6614634. doi: 10.1093.
    >> Share

  31. BOUCAU J, Uddin R, Marino C, Regan J, et al
    Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19.
    Clin Infect Dis. 2022 Jun 23. pii: 6614635. doi: 10.1093.
    >> Share

  32. TEMTE JL, Barlow S, Temte E, Goss M, et al
    SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin.
    Clin Infect Dis. 2022 Jun 23. pii: 6614626. doi: 10.1093.
    >> Share

  33. LEVY R, Cohen R, Lev-Shalem L, Eisenkraft A, et al
    A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic.
    Clin Infect Dis. 2022 Jun 20. pii: 6611849. doi: 10.1093.
    >> Share

  34. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  35. ZIPFEL CM, Paul P, Gowler CD, Reddy SC, et al
    Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes.
    Clin Infect Dis. 2022 Jun 20. pii: 6611848. doi: 10.1093.
    >> Share

  36. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    >> Share

  37. CARLIN AF, Clark AE, Chaillon A, Garretson AF, et al
    Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Jun 20. pii: 6611663. doi: 10.1093.
    >> Share

  38. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  39. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    >> Share

  40. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  41. KEATING P, Sell J, Chen J, Ackelsberg J, et al
    Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020.
    Clin Infect Dis. 2022 Jun 20. pii: 6611571. doi: 10.1093.
    >> Share

  42. GOLD JAW, Ahmad FB, Cisewski JA, Rossen LM, et al
    Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611491. doi: 10.1093.
    >> Share

  43. CZECH-SIOLI M, Gunther T, Robitaille A, Roggenkamp H, et al
    Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital.
    Clin Infect Dis. 2022 Jun 19. pii: 6611489. doi: 10.1093.
    >> Share

  44. STRID P, Zapata LB, Tong VT, Zambrano LD, et al
    COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611488. doi: 10.1093.
    >> Share

  45. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  46. HALASA NB, Spieker AJ, Young CC, Olson SM, et al
    Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children.
    Clin Infect Dis. 2022 Jun 19. pii: 6611483. doi: 10.1093.
    >> Share

  47. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  48. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    >> Share

  49. FREE H, Luckhaupt SE, Billock RM, Groenewold MR, et al
    Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611490. doi: 10.1093.
    >> Share

    Emerg Infect Dis

  50. NEVEJAN L, Cuypers L, Laenen L, Van Loo L, et al
    Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Emerg Infect Dis. 2022;28.
    >> Share

  51. MAGRO M, Parriott A, Mitsunaga T, Epson E, et al
    Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
    Emerg Infect Dis. 2022;28.
    >> Share

  52. KREMER C, Braeye T, Proesmans K, Andre E, et al
    Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
    Emerg Infect Dis. 2022;28.
    >> Share

  53. KIM JM, Sivasubramanian G
    Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.
    Emerg Infect Dis. 2022;28:1531-1533.
    >> Share

  54. KOYAMA AK, Koumans EH, Sircar K, Lavery AM, et al
    Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States.
    Emerg Infect Dis. 2022;28:1533-1536.
    >> Share

  55. SILVERMAN RA, Ceci A, Cohen A, Helmick M, et al
    Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.
    Emerg Infect Dis. 2022;28:1313-1320.
    >> Share

  56. MATSUMURA Y, Nagao M, Yamamoto M, Tsuchido Y, et al
    Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Emerg Infect Dis. 2022;28.
    >> Share

    Infect Control Hosp Epidemiol

  57. SCHNELL N, Brewer B, Young K, Brown T, et al
    Creation and Impact of Containment Units with High-Risk Zones during the COVID-19 Pandemic.
    Infect Control Hosp Epidemiol. 2022 Jun 17:1-27. doi: 10.1017/ice.2022.
    >> Share

    Int J Infect Dis

  58. ROVIDA F, Esposito GL, Rissone M, Novelli V, et al
    Characteristics and outcome of vaccinated and non-vaccinated patients hospitalized in a single Italian HUB for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00362.
    >> Share

  59. RIZZO R, Bortolotti D, Morandi L, Rizzo S, et al
    Humoral and adaptive immune responses to SARS-CoV-2 vaccine.
    Int J Infect Dis. 2022 Jun 21. pii: S1201-9712(22)00355.
    >> Share

  60. QUARANTA EG, Fusaro A, Giussani E, D'Amico V, et al
    SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00359.
    >> Share

  61. STAMBOULI N, Driss A, Gargouri F, Bahrini K, et al
    COVID-19 prophylaxis with Doxycycline and Zinc in Health Care Workers: A prospective randomized double-blind clinical trial.
    Int J Infect Dis. 2022 Jun 17. pii: S1201-9712(22)00349.
    >> Share

  62. QIN J, Wang G, Han D
    Benefits of plasma exchange on mortality in patients with COVID-19: a systematic review and meta-analysis.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00348.
    >> Share

  63. KOLLER JE, Villinger K, Lages NC, Absetz P, et al
    Individual and collective protective responses during the early phase of the COVID-19 pandemic in 10 different countries: Results from the EUCLID online-survey.
    Int J Infect Dis. 2022 Jun 13. pii: S1201-9712(22)00347.
    >> Share

    Intensive Care Med

  64. ANNANE D, Meduri GU
    Precision medicine for corticotherapy in COVID-19.
    Intensive Care Med. 2022 Jun 22. pii: 10.1007/s00134-022-06751.
    >> Share

  65. TORRES A, Motos A, Cilloniz C, Ceccato A, et al
    Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.
    Intensive Care Med. 2022 Jun 21. pii: 10.1007/s00134-022-06726.
    >> Share

  66. STEINBERG I, Chiodaroli E, Gattarello S, Cappio Borlino S, et al
    Diaphragmatic ultrasound and esophageal pressure in COVID-19 pneumonia during helmet CPAP.
    Intensive Care Med. 2022 Jun 21. pii: 10.1007/s00134-022-06785.
    >> Share

    J Infect

  67. YANG M, Li A, Jiang L, Wang Y, et al
    Regdanvimab improves disease mortality and morbidity in patients with COVID-19: a meta-analysis.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00369.
    >> Share

  68. NIYOMNAITHAM S, Toh ZQ, Licciardi PV, Wongprompitak P, et al
    Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: a randomized trial.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00370.
    >> Share

  69. RICHARDS A, Muddassir M, Sampson F, MacLachlan L, et al
    Evaluation of pre-hospital COVID-19 rapid antigen tests by paramedics and their use in a direct admission pathway: Pre-Hospital COVID-19 rapid antigen tests.
    J Infect. 2022 Jun 18. pii: S0163-4453(22)00371.
    >> Share

  70. PENG H, Wu X, Xiong S, Li C, et al
    Gout and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization analysis.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00366.
    >> Share

  71. HATCHER J, Gil E, Storey N, Brown JR, et al
    Reactivation/relapse of SARS-CoV-2 in a child following haematopoietic stem cell transplantation, confirmed by whole genome sequencing, following apparent viral clearance.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00367.
    >> Share

  72. COCHINO AV, Farkas OM, Ioan A
    Pediatric Patients with Immune-Mediated Diseases on Immunosuppressants Have Low Risk of Severe COVID-19 and No Increase in Flare Rate after SARS CoV-2 Exposure.
    J Infect. 2022 Jun 17. pii: S0163-4453(22)00365.
    >> Share

  73. COULSON JM, Adams A, Gray LA, Evans A, et al
    COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00363.
    >> Share

  74. LAZARUS R, Taucher C, Brown C, Corbic I, et al
    Safety and immunogenicity of the inactivated whole-virus adjuvanted vaccine VLA2001: a randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults.
    J Infect. 2022 Jun 16. pii: S0163-4453(22)00361.
    >> Share

    J Med Virol

  75. KONTOPOULOU K, Nakas CT, Belai C, Papazisis G, et al
    Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in immunocompromised adults in Greece: is a fourth dose necessary?
    J Med Virol. 2022 Jun 23. doi: 10.1002/jmv.27954.
    >> Share

  76. MIAO G, Peng H, Tang H, Liu Y, et al
    Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor.
    J Med Virol. 2022 Jun 22. doi: 10.1002/jmv.27951.
    >> Share

  77. TASEEN S, Nasir F, Abbas M, Altaf M, et al
    Post-pandemic World at the Mercy of Monkeypox Virus Outbreak: Time to worry or not?
    J Med Virol. 2022 Jun 22. doi: 10.1002/jmv.27948.
    >> Share

  78. CHEN JM, Li GH, Ji YF, Sun MH, et al
    A highly powerful non-specific strategy to reduce COVID-19 deaths.
    J Med Virol. 2022 Jun 21. doi: 10.1002/jmv.27949.
    >> Share

  79. PHAN T, Boes S, McCullough M, Gribschaw J, et al
    Emergence of SARS-CoV-2 Omicron BA.5 variant of concern in Western Pennsylvania, United States.
    J Med Virol. 2022 Jun 17. doi: 10.1002/jmv.27945.
    >> Share

  80. STAERK-OSTERGAARD J, Kirkeby C, Christiansen LE, Andersen MA, et al
    Evaluation of diagnostic test procedures for SARS-CoV-2 using latent class models.
    J Med Virol. 2022 Jun 17. doi: 10.1002/jmv.27943.
    >> Share

  81. WOLF JM, Petek H, Maccari JG, Nasi LA, et al
    COVID-19 pandemic in Southern Brazil: Hospitalizations, intensive care unit admissions, lethality rates, and length of stay between March 2020 and April 2022.
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27942.
    >> Share

  82. CEYLAN MR, Kankilic N, Oz O
    Are H1 and H3 haplotypes of endothelial protein C receptor (PROCR) an important factor in contracting COVID-19?
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27938.
    >> Share

  83. TIAN F, Yang R
    Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27940.
    >> Share

  84. WANG L, Zhou HY, Li JY, Cheng YX, et al
    Potential Inter-variant and Intra-variant Recombination of Delta and Omicron Variants.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27939.
    >> Share

  85. WELLS DA, Cantoni D, Mayora-Neto M, Di Genova C, et al
    Human seasonal coronavirus neutralisation and COVID-19 severity.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27937.
    >> Share

  86. AKASH K, Sharma A, Kumar D, Singh SK, et al
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27936.
    >> Share

    J Travel Med

  87. HUITS R, Hamer DH
    Malaria in sub-Saharan Africa-a continuing risk for international travellers.
    J Travel Med. 2022 Jun 23. pii: 6614631. doi: 10.1093.
    >> Share

    J Virol

  88. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    >> Share

  89. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    >> Share


  90. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
    Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
    JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
    >> Share

  91. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    >> Share

  92. RUBIN R
    Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
    JAMA. 2022;327:2281.
    >> Share

    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    >> Share


  94. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    >> Share

  95. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    >> Share

    Lancet Infect Dis

  96. VADREVU KM, Reddy S, Jogdand H, Ganneru B, et al
    Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.
    Lancet Infect Dis. 2022 Jun 16. pii: S1473-3099(22)00307.
    >> Share

    MMWR Morb Mortal Wkly Rep

  97. MALDEN DE, Hong V, Lewin BJ, Ackerson BK, et al
    Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment - California, December 2021-May 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:830-833.
    >> Share

  98. DINENNO EA, Delaney KP, Pitasi MA, MacGowan R, et al
    HIV Testing Before and During the COVID-19 Pandemic - United States, 2019-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:820-824.
    >> Share

  99. GOLD JAW, Kelleher J, Magid J, Jackson BR, et al
    Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code-Level Social Vulnerability - United States, December 23, 2021-May 21, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:825-829.
    >> Share

  100. KAMBHAMPATI AK, Burke RM, Dietz S, Sheppard M, et al
    Trends in Acute Hepatitis of Unspecified Etiology and Adenovirus Stool Testing Results in Children - United States, 2017-2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:797-802.
    >> Share

  101. LEE D, Counard C, Tang A, Brister S, et al
    Notes from the Field: COVID-19-Associated Mortality Risk Among Long-Term Care Facility Residents and Community-Dwelling Adults Aged >/=65 Years - Illinois, December 2020 and January 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:803-805.
    >> Share

  102. YUAN Y, Thierry JM, Bull-Otterson L, Yeargin-Allsopp M, et al
    COVID-19 Cases and Hospitalizations Among Medicare Beneficiaries With and Without Disabilities - United States, January 1, 2020-November 20, 2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:791-796.
    >> Share

    N Engl J Med

  103. DESILVA M, Haapala J, Vazquez-Benitez G, Vesco KK, et al
    Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2205276.
    >> Share

  104. HALASA NB, Olson SM, Staat MA, Newhams MM, et al
    Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMoa2204399.
    >> Share

  105. RASMUSSEN SA, Jamieson DJ
    Covid-19 Vaccination during Pregnancy - Two for the Price of One.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMe2206730.
    >> Share

  106. HACHMANN NP, Miller J, Collier AY, Ventura JD, et al
    Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5.
    N Engl J Med. 2022 Jun 22. doi: 10.1056/NEJMc2206576.
    >> Share

  107. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Vaccinating Young Children against Covid-19.
    N Engl J Med. 2022;386:e77.
    >> Share

  108. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
    Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
    N Engl J Med. 2022;386:e75.
    >> Share

  109. BAR-ON YM, Goldberg Y, Milo R
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Reply.
    N Engl J Med. 2022;386:2441-2442.
    >> Share

  110. WOHL A, Leibowitz R
    Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.
    N Engl J Med. 2022;386:2441.
    >> Share

  111. PRICE AM, Olson SM, Patel MM
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents. Reply.
    N Engl J Med. 2022;386:2346.
    >> Share

  112. ZENG G
    BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
    N Engl J Med. 2022;386:2345-2346.
    >> Share


  113. The pandemic's unequal toll.
    Nature. 2022 Jun 22. pii: 10.1038/d41586-022-01722.
    >> Share

  114. SIDIK SM
    How COVID has deepened inequality - in six stark graphics.
    Nature. 2022;606:638-639.
    >> Share

  115. DOLGIN E
    The science behind COVID's assault on smell.
    Nature. 2022;606:S5-S6.
    >> Share

  116. LEDFORD H
    How common is long COVID? Why studies give different answers.
    Nature. 2022 Jun 20. pii: 10.1038/d41586-022-01702.
    >> Share

    FDA authorizes COVID vaccines for the littlest kids: what the data say.
    Nature. 2022 Jun 17. pii: 10.1038/d41586-022-01689.
    >> Share

  118. CAO Y, Yisimayi A, Jian F, Song W, et al
    BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Nature. 2022 Jun 17. pii: 10.1038/s41586-022-04980.
    >> Share

  119. GRAHAM F
    Daily briefing: What's holding back new treatments for COVID-19.
    Nature. 2022 Jun 14. pii: 10.1038/d41586-022-01670.
    >> Share

    How months-long COVID infections could seed dangerous new variants.
    Nature. 2022;606:452-455.
    >> Share


  121. RAKOCEVIC N, Alaslani OH, Torres CH
    Case 303: Delayed Posthypoxic Leukoencephalopathy.
    Radiology. 2022;304:241-244.
    >> Share

  122. TSAKOK MT, Watson RA, Saujani SJ, Kong M, et al
    Chest CT and Hospital Outcomes in Patients with Omicron Compared with Delta Variant SARS-CoV-2 Infection.
    Radiology. 2022 Jun 21:220533. doi: 10.1148/radiol.220533.
    >> Share


  123. BUCHANAN CJ, Gaunt B, Harrison PJ, Yang Y, et al
    Pathogen-sugar interactions revealed by universal saturation transfer analysis.
    Science. 2022 Jun 23:eabm3125. doi: 10.1126/science.abm3125.
    >> Share

  124. YUAN S, Ye ZW, Liang R, Tang K, et al
    Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Science. 2022 Jun 23:eabn8939. doi: 10.1126/science.abn8939.
    >> Share

  125. WADMAN M
    Glacial pace for U.S. Long Covid grants.
    Science. 2022;376:1262-1263.
    >> Share

    Travel Med Infect Dis

  126. KARACIC J, Zanetti M, Marusic A
    How difficult it was to acquire COVID digital certificate in summer 2021: Response of EU national contact points for cross-border health care.
    Travel Med Infect Dis. 2022;48:102347.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016